Skip to main content

Navigation group

Type at least 3 characters
1,580 articles

Articles

Original Research

Published on 22 Jul 2022

Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine

in Alloimmunity and Transplantation

  • Magdalena Piotrowska
  • Maciej Zieliński
  • Leszek Tylicki
  • Bogdan Biedunkiewicz
  • Alicja Kubanek
  • Zuzanna Ślizień
  • Karolina Polewska
  • Piotr Tylicki
  • Marta Muchlado
  • Justyna Sakowska
Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine
Frontiers in Immunology
doi 10.3389/fimmu.2022.832924
  • 4,367 views
  • 21 citations